At the time of writing, Silence Therapeutics Plc ADR [SLN] stock is trading at $8.18, up 3.28%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SLN shares have gain 16.69% over the last week, with a monthly amount drifted -52.72%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Silence Therapeutics Plc ADR [NASDAQ: SLN] stock has seen the most recent analyst activity on December 02, 2024, when BMO Capital Markets reiterated its Outperform rating. Previously, Jefferies started tracking the stock with Buy rating on September 03, 2024, and set its price target to $40. On January 31, 2024, BMO Capital Markets initiated with a Outperform rating and assigned a price target of $67 on the stock.
For the past year, the stock price of Silence Therapeutics Plc ADR fluctuated between $5.81 and $27.72. Currently, Wall Street analysts expect the stock to reach $57 within the next 12 months. Silence Therapeutics Plc ADR [NASDAQ: SLN] shares were valued at $8.18 at the most recent close of the market. An investor can expect a potential return of 596.82% based on the average SLN price forecast.
Analyzing the SLN fundamentals
According to Silence Therapeutics Plc ADR [NASDAQ:SLN], the company’s sales were 20.57M for trailing twelve months, which represents an -58.07% plunge. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -3.59%, Pretax Profit Margin comes in at -4.06%, and Net Profit Margin reading is -3.62%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.68 and Total Capital is -0.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.73 points at the first support level, and at 7.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 8.72, and for the 2nd resistance point, it is at 9.25.
Ratios To Look Out For
It is important to note that Silence Therapeutics Plc ADR [NASDAQ:SLN] has a current ratio of 9.31. Also, the Quick Ratio is 9.31, while the Cash Ratio stands at 3.66. Considering the valuation of this stock, the price to sales ratio is 18.77, the price to book ratio is 3.05.
